BG ALIUD / STADAPHARM GbR secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient molsidomine ATC C01DX12 for the period 01052024 - 30042026

Germany, April 27 -- Germany based BG ALIUD / STADAPHARM GbR has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient molsidomine ATC C01DX12 for the period 01052024 - 30042026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....